Novartis announces FDA approval of Xolair® (omalizumab) for pediatric allergic asthma
Source URL: https://qa1.novartis.us/us-en/news/media-releases/novartis-announces-fda-approval-xolair-omalizumab-pediatric-allergic-asthma-0
List of links present in page
- https://qa1.novartis.us/us-en/us-en/news/media-releases/novartis-announces-fda-approval-xolair-omalizumab-pediatric-allergic-asthma-0